Biocon Receives Order-in-Original for ₹1.85 Crore GST Demand, FY23 Applicable
Biocon Limited received an Order-in-Original confirming a GST demand of ₹1.85 crore for FY23. The order also includes interest of ₹1.17 crore and a penalty of ₹18.52 lakh. The company disputes the demand and plans to file an appeal.
While the company states there is no material impact, the demand for tax, interest, and penalty could have a financial impact. The company's intention to appeal suggests it considers the matter significant.
The company has received a significant tax demand, interest, and penalty, which is a negative development.
Biocon Limited has received an Order-in-Original from the Office of the Assistant Commissioner (ST), Atchuthapuram circle, Visakhapatnam, Andhra Pradesh, concerning Goods and Services Tax.
The order, dated October 9, 2026, confirms a demand of ₹1,85,28,762/- for Goods and Services tax, along with interest of ₹1,17,59,033/- and a penalty of ₹18,52,476/-. The issues cited include non-submission of Special Economic Zone (SEZ) endorsement documents for zero-rated SEZ supplies, input tax reversed under temporary reversal instead of permanent reversal, and improper claim of Input Service Distribution credits.
This communication is applicable for the Financial Year 2022-23. Biocon stated that there is no material impact on the financials, operations, or other activities of the Company, with the impact limited to the final liability, interest, and penalty. The company intends to take appropriate actions, including filing a Rectification Application or an Appeal.
What to do with a filing like this
Biocon Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Biocon Limited. Read the original for the full detail.